MORF 057

· Morphic Therapeutic, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MORF 057, covering 2024-11-26 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease [Phase 2]